Clinical trials
Phase 1 Mesothelioma, Malignant trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2019 | 2 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 4 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ascentage Pharma Group Inc. | 1 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 1 |
| Chinese PLA General Hospital | 1 |
| Multitude Therapeutics Inc. | 1 |
| Suzhou Maximum Bio-tech Co., Ltd. | 1 |
| UTC Therapeutics Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mesothelioma, Malignant | 6 |
| Ovarian Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Endometrial Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Adenocarcinoma of Lung | 1 |
| Bile Duct Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.